On the other hand, Ashina and colleagues recently reported that a monoclonal antibody targeting PACAP has demonstrated efficacy in migraine prophylaxis [43], despite PACAP being less expressed in the TG compared to CGRP. This evidence concerns the gene CALCA and migraine disorder.